Highlights

25/02 Galderma Announces Triple Approval of New Restylane Syringe in the EU, the U.S., and Canada CI
13/02 Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025 CI
12/11 Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026 CI
12/11 Terumo Corporation Announces Dividend for the Second Quarter End of 2026, Payable on December 2, 2025; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2026 CI
12/11 Terumo Attributable Profit Jumps 22% in Fiscal H1; Cuts Full Year Profit Forecasts MT
12/11 Terumo Corporation Reports Earnings Results for the Half Year Ended September 30, 2025 CI
11/11 Orchestra BioMed Q3 revenue beats expectations RE
30/25/30 Terumo Corporation completed the acquisition of remaining 99.5% stake in OrganOx Limited from a group of shareholders. CI
24/25/24 Terumo Interventional Systems Announces its New OPUSWAVE Dual Sensor Imaging System and DualView®? Imaging Catheter Receive FDA 510(k) Clearance CI
24/25/24 Alert wrongly tagged to Man Zai Industrial Co withdrawn RE
24/25/24 Terumo Interventional Systems' Opuswave Dual Sensor Imaging System gets FDA 510(k) clearance RE
22/25/22 The Blood Center in New Orleans Modernizes Platelet Processing with FDA-cleared Automated Blood Processing System from Terumo Blood and Cell Technologies CI
29/25/29 For interim dividend FA
26/25/26 PRESS DIGEST-British Business - Aug 26 RE
25/25/25 Japan Shares Edge Higher As Investors Bet On US Fed Cuts, Await Nvidia Results MT
25/25/25 Terumo to Buy UK's OrganOx for $1.5 Billion to Expand Into Organ Transplant Sector MT
25/25/25 Terumo to Buy U.K.-Based OrganOx for $1.5 Billion DJ
25/25/25 Terumo Corp - will acquire Organox RE
23/25/23 Terumo Corporation has entered into a definitive agreement to acquire 99.5% stake in OrganOx Limited from a group of shareholders in a transaction valued at $1.5 billion. CI
07/25/07 Terumo's Profit Jumps 24% in Fiscal Q1 MT
02/25/02 Terumo Neuro Announces EMEA Commercial Availability of the SOFIA?? Flow 88 Neurovascular Aspiration Catheter CI
28/25/28 Terumo Interventional Systems, Division of Terumo Corporation, Announces Commercial Availability of its ROADSAVER Carotid Stent System CI
14/25/14 Terumo Profit Gains 10% in Fiscal 2025 MT
14/25/14 Terumo Says It And Wuxi Biologics Enter Into Agreement On A Drug Product Plant In Leverkusen, Germany RE
14/25/14 Terumo Corporation Reports Earnings Results for the Full Year Ended March 31, 2025 CI
No results for this search
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW